PainReform Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Ehud Geller
Chief executive officer
US$181.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 16.5yrs |
| CEO ownership | n/a |
| Management average tenure | 5.7yrs |
| Board average tenure | 5.3yrs |
Recent management updates
CEO
Ehud Geller
16.5yrs
Tenure
US$181,000
Compensation
Dr. Ehud Geller, Ph D., has been the Executive Chairman of PainReform Ltd. since November 2008 and also serves as its Interim CEO and had been its Acting Chief Financial Officer since January 2020 until De...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO & Executive Chairman | no data | US$181.00k | no data | |
| Interim Chief Financial Officer | less than a year | US$235.00k | 0% $ 0 | |
| Chief Operating Officer | 11.3yrs | US$347.00k | 0% $ 0 | |
| CTO & Director | 7.1yrs | US$167.00k | 0% $ 0 | |
| Vice President of Pharmaceutical Operations | 4.3yrs | US$355.00k | 0% $ 0 | |
| Executive Vice President of Development | no data | no data | no data |
5.7yrs
Average Tenure
55yo
Average Age
Experienced Management: PRFX's management team is seasoned and experienced (5.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO & Executive Chairman | 16.5yrs | US$181.00k | no data | |
| CTO & Director | 5.4yrs | US$167.00k | 0% $ 0 | |
| Independent External Director | 4.7yrs | no data | 0% $ 0 | |
| Independent External Director | 4.7yrs | no data | 0% $ 0 | |
| Independent Director | 5.3yrs | no data | 0% $ 0 |
5.3yrs
Average Tenure
69yo
Average Age
Experienced Board: PRFX's board of directors are considered experienced (5.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/07 05:39 |
| End of Day Share Price | 2025/05/07 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PainReform Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason McCarthy | Maxim Group |
| Nazibur Rahman | Maxim Group |